$PLx Pharma (PLXP.US)$PLx Pharma Says As Result Of Receiving...
$PLx Pharma (PLXP.US)$ PLx Pharma Says As Result Of Receiving Written Notice From Nasdaq Listing Qualifications Department; Says Unless Co. Requests Appeal Of Nasdaq Determination, Co.'s Common Stock Will Be Suspended From Nasdaq Capital Market On Apr. 13, 2023
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
